Identification of mammalian protein quality control factors by high-throughput cellular imaging.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 3282772)

Published in PLoS One on February 20, 2012

Authors

Gianluca Pegoraro1, Ty C Voss, Scott E Martin, Pinar Tuzmen, Rajarshi Guha, Tom Misteli

Author Affiliations

1: Cell Biology of Genomes, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.

Articles cited by this

Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65

Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol (2007) 33.06

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature (2002) 19.77

Protein folding and misfolding. Nature (2003) 14.92

Adapting proteostasis for disease intervention. Science (2008) 13.22

Identification of host proteins required for HIV infection through a functional genomic screen. Science (2008) 12.44

HSP90 and the chaperoning of cancer. Nat Rev Cancer (2005) 11.98

Principles of cancer therapy: oncogene and non-oncogene addiction. Cell (2009) 10.96

Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem (2009) 8.83

One step at a time: endoplasmic reticulum-associated degradation. Nat Rev Mol Cell Biol (2008) 8.68

Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature (2000) 7.10

Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer (2010) 6.81

Complementation analysis of simian virus 40 mutants. J Virol (1974) 6.71

Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev (2008) 6.18

Converging concepts of protein folding in vitro and in vivo. Nat Struct Mol Biol (2009) 5.47

Ubiquitin-conjugating enzymes UBC4 and UBC5 mediate selective degradation of short-lived and abnormal proteins. EMBO J (1990) 5.31

Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells. Nat Biotechnol (2000) 5.14

Misfolded proteins partition between two distinct quality control compartments. Nature (2008) 4.75

Heat shock factors: integrators of cell stress, development and lifespan. Nat Rev Mol Cell Biol (2010) 4.63

Analysis of cell-based RNAi screens. Genome Biol (2006) 3.99

Global protein stability profiling in mammalian cells. Science (2008) 3.91

Quality control of mitochondria: protection against neurodegeneration and ageing. EMBO J (2008) 3.39

Genetic suppression of polyglutamine toxicity in Drosophila. Science (2000) 3.23

eIF3: a versatile scaffold for translation initiation complexes. Trends Biochem Sci (2006) 3.12

Degradation-mediated protein quality control in the nucleus. Cell (2005) 3.10

Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat Cell Biol (2008) 2.93

Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science (2003) 2.89

Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc Natl Acad Sci U S A (2004) 2.89

Bortezomib: proteasome inhibition as an effective anticancer therapy. Annu Rev Med (2006) 2.72

Phosphorylation of T-antigen and control T-antigen expression in cells transformed by wild-type and tsA mutants of simian virus 40. J Virol (1979) 2.59

Ageing-related chromatin defects through loss of the NURD complex. Nat Cell Biol (2009) 2.40

Ump1p is required for proper maturation of the 20S proteasome and becomes its substrate upon completion of the assembly. Cell (1998) 2.39

Detecting and measuring cotranslational protein degradation in vivo. Science (2000) 2.34

A noncytotoxic DsRed variant for whole-cell labeling. Nat Methods (2008) 2.34

Ubiquitin depletion as a key mediator of toxicity by translational inhibitors. Mol Cell Biol (2003) 2.29

Protein quality control: chaperones culling corrupt conformations. Nat Cell Biol (2005) 2.20

Cytoplasmic protein quality control degradation mediated by parallel actions of the E3 ubiquitin ligases Ubr1 and San1. Proc Natl Acad Sci U S A (2009) 2.05

Intracellular localization of proteasomal degradation of a viral antigen. J Cell Biol (1999) 2.04

Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of Mammalian proteasomes. J Biol Chem (2003) 1.87

Proteasome-mediated degradation of cotranslationally damaged proteins involves translation elongation factor 1A. Mol Cell Biol (2005) 1.74

Protein synthesis elongation factor EF-1 alpha is essential for ubiquitin-dependent degradation of certain N alpha-acetylated proteins and may be substituted for by the bacterial elongation factor EF-Tu. Proc Natl Acad Sci U S A (1994) 1.72

IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. Proc Natl Acad Sci U S A (2005) 1.70

The eIF3 interactome reveals the translasome, a supercomplex linking protein synthesis and degradation machineries. Mol Cell (2009) 1.45

A nucleus-based quality control mechanism for cytosolic proteins. Mol Biol Cell (2010) 1.28

Dissecting beta-ring assembly pathway of the mammalian 20S proteasome. EMBO J (2008) 1.28

Tight linkage between translation and MHC class I peptide ligand generation implies specialized antigen processing for defective ribosomal products. J Immunol (2006) 1.27

The dynamics of ubiquitin pools within cultured human lung fibroblasts. J Biol Chem (1987) 1.26

A yeast Ubc9 mutant protein with temperature-sensitive in vivo function is subject to conditional proteolysis by a ubiquitin- and proteasome-dependent pathway. J Biol Chem (1996) 1.20

Characterisation of the newly identified human Ump1 homologue POMP and analysis of LMP7(beta 5i) incorporation into 20 S proteasomes. J Mol Biol (2000) 1.19

The proteasome maturation protein POMP facilitates major steps of 20S proteasome formation at the endoplasmic reticulum. EMBO Rep (2007) 1.18

Microinjection of ubiquitin: intracellular distribution and metabolism in HeLa cells maintained under normal physiological conditions. J Cell Biol (1987) 1.13

Analysis of quality control substrates in distinct cellular compartments reveals a unique role for Rpn4p in tolerating misfolded membrane proteins. Mol Biol Cell (2008) 1.09

Neurodegenerative diseases: Lessons from genome-wide screens in small model organisms. EMBO Mol Med (2009) 1.00

Identification and characterization of a mammalian protein interacting with 20S proteasome precursors. Proc Natl Acad Sci U S A (2000) 0.99

Differential expression of normal and mutant Huntington's disease gene alleles. Neurobiol Dis (1996) 0.97

Possible tetramerisation of the proteasome maturation factor POMP/proteassemblin/hUmp1 and its subcellular localisation. Int J Biol Macromol (2006) 0.87

Interplay between protein homeostasis networks in protein aggregation and proteotoxicity. Biopolymers (2010) 0.83

Aberrant DNA polymerase alpha is excluded from the nucleus by defective import and degradation in the nucleus. J Biol Chem (2009) 0.77

Articles by these authors

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature (2002) 19.77

RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E). Nature (2011) 10.77

Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev Cell (2006) 8.53

Regulation of alternative splicing by histone modifications. Science (2010) 7.98

Recent developments of the chemistry development kit (CDK) - an open-source java library for chemo- and bioinformatics. Curr Pharm Des (2006) 7.05

Lamin A-dependent nuclear defects in human aging. Science (2006) 6.71

Global transcription in pluripotent embryonic stem cells. Cell Stem Cell (2008) 5.81

Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell (2007) 5.62

The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc Natl Acad Sci U S A (2003) 5.59

Chromatin in pluripotent embryonic stem cells and differentiation. Nat Rev Mol Cell Biol (2006) 5.18

Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome. Nat Med (2005) 5.01

Epigenetics in alternative pre-mRNA splicing. Cell (2011) 4.74

Maintenance of stable heterochromatin domains by dynamic HP1 binding. Science (2003) 4.74

A kinetic framework for a mammalian RNA polymerase in vivo. Science (2002) 4.42

Global nature of dynamic protein-chromatin interactions in vivo: three-dimensional genome scanning and dynamic interaction networks of chromatin proteins. Mol Cell Biol (2004) 4.41

Positional stability of single double-strand breaks in mammalian cells. Nat Cell Biol (2007) 4.35

Transcription dynamics. Mol Cell (2009) 4.15

Spatial proximity of translocation-prone gene loci in human lymphomas. Nat Genet (2003) 3.91

Interaction of the glucocorticoid receptor with the chromatin landscape. Mol Cell (2008) 3.42

Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets. Science (2011) 3.30

Activation of the cellular DNA damage response in the absence of DNA lesions. Science (2008) 3.17

Measurement of dynamic protein binding to chromatin in vivo, using photobleaching microscopy. Methods Enzymol (2004) 3.02

Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma. Cancer Cell (2012) 3.00

Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat Cell Biol (2008) 2.93

TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression. Proc Natl Acad Sci U S A (2008) 2.58

Tissue-specific spatial organization of genomes. Genome Biol (2004) 2.57

Distinct structural and mechanical properties of the nuclear lamina in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A (2006) 2.53

High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells. Proc Natl Acad Sci U S A (2014) 2.50

Cell biology: chromosome territories. Nature (2007) 2.47

Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription. Nat Cell Biol (2009) 2.46

DNA damage defines sites of recurrent chromosomal translocations in B lymphocytes. Nature (2012) 2.44

Ageing-related chromatin defects through loss of the NURD complex. Nat Cell Biol (2009) 2.40

Neural induction promotes large-scale chromatin reorganisation of the Mash1 locus. J Cell Sci (2006) 2.37

Network of dynamic interactions between histone H1 and high-mobility-group proteins in chromatin. Mol Cell Biol (2004) 2.33

Chromosome positioning in the interphase nucleus. Trends Cell Biol (2002) 2.32

The ATM repair pathway inhibits RNA polymerase I transcription in response to chromosome breaks. Nature (2007) 2.30

Targeting IRAK1 as a therapeutic approach for myelodysplastic syndrome. Cancer Cell (2013) 2.22

The meaning of gene positioning. Cell (2008) 2.16

Functional implications of genome topology. Nat Struct Mol Biol (2013) 2.13

Spatial genome organization in the formation of chromosomal translocations. Semin Cancer Biol (2006) 2.12

HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat Med (2004) 1.97

Spatial dynamics of chromosome translocations in living cells. Science (2013) 1.95

Alcohol availability as a predictor of youth drinking and driving: a hierarchical analysis of survey and archival data. Alcohol Clin Exp Res (2003) 1.94

Mapping the interaction surface of linker histone H1(0) with the nucleosome of native chromatin in vivo. Nat Struct Mol Biol (2006) 1.94

In vivo kinetics of Cajal body components. J Cell Biol (2004) 1.91

Condensed mitotic chromatin is accessible to transcription factors and chromatin structural proteins. J Cell Biol (2004) 1.86

The lamin protein family. Genome Biol (2011) 1.85

Functional association of Sun1 with nuclear pore complexes. J Cell Biol (2007) 1.81

Human chromokinesin KIF4A functions in chromosome condensation and segregation. J Cell Biol (2004) 1.81

Diverse gene reprogramming events occur in the same spatial clusters of distal regulatory elements. Genome Res (2011) 1.80

Competition between histone H1 and HMGN proteins for chromatin binding sites. EMBO Rep (2002) 1.74

The identification of microRNAs in a genomically unstable region of human chromosome 8q24. Mol Cancer Res (2008) 1.71

Biogenesis of nuclear bodies. Cold Spring Harb Perspect Biol (2010) 1.69

PubChem as a source of polypharmacology. J Chem Inf Model (2009) 1.68

Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer. Cancer Res (2006) 1.64

Allele-specific nuclear positioning of the monoallelically expressed astrocyte marker GFAP. Genes Dev (2008) 1.62

In vitro generation of human cells with cancer stem cell properties. Nat Cell Biol (2011) 1.61

Defining and assaying RNAi in mammalian cells. Mol Cell (2005) 1.60

Quantitation of GFP-fusion proteins in single living cells. J Struct Biol (2002) 1.59

Conservation of relative chromosome positioning in normal and cancer cells. Curr Biol (2002) 1.58

Locus-specific and activity-independent gene repositioning during early tumorigenesis. J Cell Biol (2008) 1.56

The road much traveled: trafficking in the cell nucleus. Curr Opin Cell Biol (2006) 1.52

A cyclophilin functions in pre-mRNA splicing. EMBO J (2002) 1.49

Modulation of RNA polymerase assembly dynamics in transcriptional regulation. Mol Cell (2008) 1.47

Rrn3 phosphorylation is a regulatory checkpoint for ribosome biogenesis. J Biol Chem (2002) 1.45

Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma. Proc Natl Acad Sci U S A (2009) 1.44

Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells. Mol Cancer Ther (2006) 1.41

Chromokinesins: multitalented players in mitosis. Trends Cell Biol (2005) 1.41

Spatial genome organization. Exp Cell Res (2004) 1.39

LINC complexes in health and disease. Nucleus (2011) 1.37

Mobility and immobility of chromatin in transcription and genome stability. Curr Opin Genet Dev (2007) 1.37

Lamin A/C-mediated neuromuscular junction defects in Emery-Dreifuss muscular dystrophy. J Cell Biol (2009) 1.36

Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death. Proc Natl Acad Sci U S A (2013) 1.36

Web service infrastructure for chemoinformatics. J Chem Inf Model (2007) 1.34

Synthetic mimics of small Mammalian cell surface receptors. J Am Chem Soc (2004) 1.34

Chemoinformatic analysis of combinatorial libraries, drugs, natural products, and molecular libraries small molecule repository. J Chem Inf Model (2009) 1.32

Implication of checkpoint kinase-dependent up-regulation of ribonucleotide reductase R2 in DNA damage response. J Biol Chem (2009) 1.31

Aberrant nuclear trafficking of La protein leads to disordered processing of associated precursor tRNAs. Mol Cell (2002) 1.30

Userscripts for the life sciences. BMC Bioinformatics (2007) 1.29

Profile of the GSK published protein kinase inhibitor set across ATP-dependent and-independent luciferases: implications for reporter-gene assays. PLoS One (2013) 1.27

In vivo dynamics of Swi6 in yeast: evidence for a stochastic model of heterochromatin. Mol Cell Biol (2004) 1.26

Potential roles for ubiquitin and the proteasome during ribosome biogenesis. Mol Cell Biol (2006) 1.25

Open Data, Open Source and Open Standards in chemistry: The Blue Obelisk five years on. J Cheminform (2011) 1.22

Tobacco free workplace policies and low socioeconomic status female bartenders in San Francisco. J Epidemiol Community Health (2006) 1.21

An uncertainty principle in chromosome positioning. Trends Cell Biol (2003) 1.19

Post-natal myogenic and adipogenic developmental: defects and metabolic impairment upon loss of A-type lamins. Nucleus (2011) 1.19

More than a splicing code: integrating the role of RNA, chromatin and non-coding RNA in alternative splicing regulation. Curr Opin Genet Dev (2011) 1.18

Eliminating the impact of the Impact Factor. J Cell Biol (2013) 1.15

MicroRNAs and genomic instability. Semin Cancer Biol (2006) 1.14

Identification of differential protein interactors of lamin A and progerin. Nucleus (2010) 1.14

Disease-specific gene repositioning in breast cancer. J Cell Biol (2009) 1.13

Diversity-Oriented Synthesis Yields a Novel Lead for the Treatment of Malaria. ACS Med Chem Lett (2011) 1.12

Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family. Cancer Res (2012) 1.11

Towards interoperable and reproducible QSAR analyses: Exchange of datasets. J Cheminform (2010) 1.11

Nucleolomics: an inventory of the nucleolus. Mol Cell (2002) 1.10

Recruitment of dioxin receptor to active transcription sites. Mol Biol Cell (2002) 1.08

The central role of chromatin maintenance in aging. Aging (Albany NY) (2009) 1.07